Global Platelet Rich Plasma MarketAugust 27, 2021 ⚊ 5 Min read ⚊ Views 259 ⚊ BUSINESS
Global Platelet Rich Plasma Market was valued US$ 219.99 Mn in 2019 and is expected to reach US$ XX Mn by 2026, at a CAGR of XX % during a forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The major driving factors of the global platelet-rich plasma market have increased the incidence of orthopedic & sports injuries, the rising number of cosmetic surgical procedures, technological advancements & regulatory approvals for new devices, increasing the popularity of platelet-rich plasma products and treatments, and growing awareness about platelet-rich plasma therapies.
Standardization in quality of allergen extracts, difficulty in quality control of test results, use of platelet-rich plasma in patients suffering from diabetes & kidney ailments is restricted, and regenerative medicine developments in other fields are hampering the global platelet-rich plasma market growth. The report contains a detailed list of factors that will drive and restrain the growth of the platelet-rich plasma market globally.
The platelet-rich plasma market is segmented into a product type, application, origin, end-user, and region. Based on product type, the platelet-rich plasma market is segmented into pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, and leukocyte rich fibrin. Based on the application segment, the platelet-rich plasma market is classified into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others. Based on origin, the autologous platelet-rich plasma held the largest market share due to the low threat of disease transmission, cost-effectiveness, and easy production.
By application, the orthopedics segment is anticipated to lead the market for platelet-rich plasma during the forecast period. The increase in accidents causing orthopedic disorders and the rise in sports injuries are mainly boosting the demand for platelet-rich plasma market.
The report offers a brief analysis of the major regions in the platelet-rich plasma market, namely, Asia-Pacific, Europe, North America, Latin America, and the Middle East & Africa. The Asia Pacific is expected to show the highest growth, due to the increase in the number of people suffering from osteoporosis. The rise in the number of accidents, growing awareness about technologically advanced platelet rich plasma market products, and rise in the occurrences of neurological disorders are some other factors increasing the expansion of platelet rich plasma market in the Asia Pacific region.
The objective of the report is to present comprehensive analysis of Global Platelet Rich Plasma Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Global Platelet Rich Plasma Market dynamics, structure by analyzing the market segments, and project the Global Platelet Rich Plasma Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Platelet Rich Plasma Market make the report investor’s guide.
Scope of Market:
Market, by Product Type:
• Pure Platelet Rich Plasma
• Leukocyte Rich Platelet Rich Plasma
• Leukocyte Rich Fibrin
Market, by Application:
• Cardiac Muscle Injury
• Nerve Injury
Market, by Origin:
• Allogeneic Platelet Rich Plasma
• Autologous Platelet Rich Plasma
• Homologous Platelet Rich Plasma
Market, by End-user:
• Hospitals & Clinics
• Research Institutions
Market, by Region:
• North America
• Asia Pacific
• Latin America
• Middle East & Africa
The key player operating in the Global Platelet Rich Plasma Market:
• Bio Product Laboratory Ltd
• Biolife Plasma Services
• Cambryn Biologics Llc
• China Biologic Products Inc.
• Csl Ltd
• Grifols International S.A.
• Kedrion S.P.A.
• Lfb Sa
• t-lab prp kit
• Arthrex, Inc.
• TERUMO BCT, INC.
• EmCyte Corporation
• DePuy Synthes Companies
• Zimmer Biomet,
• Stryker Corporation
• Glofinn OY
• Dr. PRP USA LLC
• AdiStem, Ltd.
• CellMedix Holdings, LLC
• Exatech, Inc.
• Cesca Therapeutics, Inc.About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address: Maximize Market Reseach Pvt Ltd. 3rd floor, office no. 4, Navale IT zone phase-2, Mumbai -Banglore bypass highway, Pune- 411041